# Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR

> **NCT04461223** · — · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 55 (estimated)

## Conditions studied

- Cardiotoxicity
- Osteosarcoma
- Myocardial Injury
- Chemotherapy Induced Systolic Dysfunction
- Doxorubicin Induced Cardiomyopathy

## Interventions

- **DIAGNOSTIC_TEST:** contrast-enhanced cardiac magnetic resonance imaging(MAGNETOM Aera 1.5T)

## Key facts

- **NCT ID:** NCT04461223
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04461223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04461223, "Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04461223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*